A61K2236/39

Methods of treatment using extracts of Anisomeles heyneana

The present invention describes the use of pharmaceutical compositions including compounds of formula 2 (below) for treatment of infections related to M. tuberculosis and for anti-proliferative activity. Also, the present invention discloses a process of extraction of compounds of formula 2 from the extract of aerial parts of Anisomeles heyneana: ##STR00001##

SYSTEMS, METHODS, AND EQUIPMENT FOR CHEMICAL EXTRACTION

Novel thermal evaporative processes for the recovery of heat-sensitive constituents, raw essential oil concentrates, and other compounds from plant biomass material are disclosed, as are systems for implementing such processes. Particularly, the processes include a solvent-less process for either batch-wise or continuous removal and recover), of refined oils, such as volatile aroma components and heavier oils, from plant material.

PHYTOCHEMICAL EXTRACTION SYSTEM AND METHODS TO EXTRACT PHYTOCHEMICALS FROM PLANTS INCLUDING PLANTS OF THE FAMILY CANNABACEAE SENSU STRICTO
20170333809 · 2017-11-23 ·

A method and system of and for extraction or removal of phytochemicals from plants, including those of the plant family Cannabaceae sensu stricto. More specifically, a method and system for extracting essential oils from plants, such as cannabis, without the use of a solvent.

Synthesis of adansonia digitata nanoparticles

A method of preparing Adansonia digitata nanoparticles includes dissolving Adansonia digitata plant powder in an organic solvent to form a solution; spraying the solution in boiling water while applying ultrasonic energy to form a mixture; and stirring the mixture for at least about 15 minutes at a speed of about 200-800 rpm to obtain the Adansonia digitata nanoparticles.

ORAL SPRAY CONTAINING IXERIS DENTATA NAKAI EXTRACT AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING XEROSTOMIA CAUSED BY DIABETES

An oral spray formulation using an Ixeris dentata Nakai extract as an active ingredient of a composition for preventing and treating xerostomia occurring as a diabetic complication, particularly an oral spray formulation capable of administering a drug through a simple and rapidly absorbable route is provided. The secretion of saliva is reduced as cells from a submandibular gland tissue of a diabetes model animal are destroyed. However, when the Ixeris dentata Nakai extract of the present invention is sublingually sprayed into a sublingual region of the diabetes model animal, expression levels of α-amylase, AQP5 and NHE1 can significantly increase, resulting in an increased secretion quantity and rate of saliva.

When the Ixeris dentata Nakai extract is administered using the formulation of the present invention, the Ixeris dentata Nakai extract is sublingually sprayed through the spray formulation, and thus can be directly locally administered to a salivary gland tissue having an activity to induce secretion of saliva. Therefore, saliva secretion can be induced by rapid absorption of the active ingredient of the Ixeris dentata Nakai extract in the salivary gland tissue without any absorption process through the digestive system, resulting in minimized side effects.

METHOD FOR EXTRACTING HIGH-PURITY ASARININ BY SUPERCRITICAL CARBON DIOXIDE EXTRACTION METHOD AND USE THEREOF

The invention discloses a method for extracting high-purity asarinin and use thereof. The method comprises: putting crude asarum powder in an SFE-CO.sub.2 device; under the conditions that an extraction kettle has a pressure of 30-40 Mpa and a temperature of 45-70° C., separating kettles I and II have a pressure of 5-10 Mpa, a temperature of 30-50° C. and the flow rate of CO.sub.2 is 35-60 L/h, extracting for 60-240 min to obtain total volatile oil of asarum; standing the total volatile oil of asarum for 24-72 h at a low temperature, and carrying out suction filtration under reduced pressure to obtain crude asarinin; and re-crystallizing the crude asarinin in absolute ethanol twice to obtain pure asarinin. It is found for the first time that asarinin has a good cough-relieving activity and thus can be used in preparing medicines for treating various types of coughs.

Medicinal composition of extract of seed of Emblica officinalis and method of preparing the same
09775869 · 2017-10-03 ·

A composition having an extract of seed of Emblica officinalis. Methods of preparing extract of seed of Emblica officinalis. An amla seed blend composition having various ratios of extracts of seeds of Emblica officinalis. Nutraceutical or pharmaceutical methods for decreasing the total cholesterol, decreasing triglyceride, decreasing blood glucose level, enhancing HDL-C levels, increasing the HDL-C level to total cholesterol ratio, lowering LDL-C levels, decreasing the CRP level, decreasing the intima media thickening, reducing hair fall in mammals especially human beings. The extract of seed of Emblica officinalis, or the amla seed blend composition is more effective compared to extracts prepared from fruits of Emblica officinalis.

METHOD OF JUICING CANNABIS PLANT MATTER
20170274028 · 2017-09-28 · ·

A method is provided, comprising steps: (a) harvesting Cannabis plant matter predetermined time; (b) grinding the Cannabis plant matter; (c) inserting the ground Cannabis plant mater into a mesh filter bag; (d) pressing the mesh filter bag via a hydraulic press at a first speed and a first pressure, wherein the ground Cannabis plant matter is separated into Cannabis pulp and Cannabis juice; and (e) collecting the Cannabis juice for consumption.

PHARMACEUTICAL COMPOSITION FOR TREATING INFERTILITY, AND PREPARATION METHOD AND USE THEREOF
20170246230 · 2017-08-31 ·

The present invention provides a drug combination for the treatment of infertility and its crude drug comprises the medical ingredients with their weight proportions listed as below: 10-20 amounts by weight of Rehmannia, 10-20 amounts by weight of Chinese Peony, 10-20 amounts by weight of Asiatic Dogwood, 10-20 amounts by weight of Chinese Yam, 10-20 amounts by weight of Poria, 15-25 amounts by weight of Astragalus, 15-25 amounts by weight of Codonopsis, 10-20 amounts by weight of Epimedium and 10-20 amounts by weight of Jujube. The compatibility of this drug combination invented is precise, appropriate and possess outstanding curative effects. As shown in many experiments, the drug combination invented is safe and reliable, its toxic & side-effect is low and it has obvious improvement effects on female infertility caused by androgen, fallopian tube inflammation, tubal blockage and other factors. Furthermore, it can not only significantly improve the success rate of pregnancy, but also improve immunity and enhance the body's anti-fatigue and hypoxia tolerance. In short, the invention provides a safe and reliable new choice for clinical medication.

Okra as a substitute for cervical mucus

Artificial cervical fluid is disclosed that contains a mucilaginous extract from the okra plant. The mucilaginous extract can be produced using a hot aqueous extractant or cold extraction process followed by separation of larger particles from the extract. The extract finds many uses, for example as a sperm storage medium, a sperm freezing medium, a sexual lubricant, an artificial insemination medium, and an in vitro fertilization medium.